RecruitingNot applicableNCT06693310
STOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological Remission
Sponsor: University of Chicago
Chicago, IL
Ulcerative Colitis clinical trials in Chicago, IL
17 recruiting ulcerative colitis studies with a site in Chicago, IL.
RecruitingPhase 3NCT07071519
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
Sponsor: AbbVie
Chicago, IL · +11 more sites
RecruitingPhase 2NCT07186101
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Sponsor: Eli Lilly and Company
Belleville, IL · Chicago, IL · Des Plaines, IL · +37 more sites
RecruitingPhase 2NCT07415044
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Sponsor: Eli Lilly and Company
Chicago, IL · Des Plaines, IL · +49 more sites
RecruitingPhase 2NCT07483073
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Sponsor: Eli Lilly and Company
Chicago, IL · +13 more sites
RecruitingPhase 3NCT06937086
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Sponsor: Eli Lilly and Company
Chicago, IL · +36 more sites
RecruitingPhase 2NCT07012395
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Sponsor: Spyre Therapeutics, Inc.
Chicago, IL · +25 more sites
RecruitingPhase 1NCT03816345
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Sponsor: National Cancer Institute (NCI)
Chicago, IL · +49 more sites
RecruitingPhase 2NCT06979336
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Sponsor: Genentech, Inc.
Chicago, IL · +7 more sites
RecruitingPhase 4NCT06095128
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Sponsor: Takeda
Chicago, IL · +36 more sites
RecruitingPhase 3NCT07184996
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Sponsor: Sanofi
Chicago, IL · Des Plaines, IL · Glenview, IL · +115 more sites
RecruitingNot applicableNCT05230173
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Sponsor: Mayo Clinic
Chicago, IL · +23 more sites
RecruitingPhase not listedNCT06398626
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
Sponsor: Pfizer
Chicago, IL · Naperville, IL · +25 more sites
RecruitingPhase 2NCT05287126
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
Sponsor: Pfizer
Chicago, IL · +19 more sites
RecruitingPhase 2NCT07427017
Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies
Sponsor: Northwestern University
Chicago, IL
Not yet recruitingNot applicableNCT07796568
Virtual Group Therapy for IBD Patients With Anxiety and Depression
Sponsor: University of Chicago
Chicago, IL
Not yet recruitingNot applicableNCT07590518
VR Therapies for IBD
Sponsor: Brennan Spiegel
Chicago, IL · +1 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.